Recommendations Summary
ONC: Nutrition Status and Outcomes of Adult Oncology Patients 2013
Click here to see the explanation of recommendation ratings (Strong, Fair, Weak, Consensus, Insufficient Evidence) and labels (Imperative or Conditional). To see more detail on the evidence from which the following recommendations were drawn, use the hyperlinks in the Supporting Evidence Section below.
-
Recommendation(s)
ONC: Nutrition Status and Outcomes in Adult Oncology Patients
The registered dietitian nutritionist (RDN) should collaborate with other health care professionals, administrators and public policy decision-makers to ensure that the evaluation of nutrition status is a key component of the adult oncology patient care process. Research indicates that poor nutrition status is associated with higher rates of hospital admissions or re-admissions, increased length of hospital stay (LOS), lower quality of life (QoL) and mortality in adult oncology patients. Poor nutrition status is also associated with decreased tolerance to chemotherapy and radiation treatment in adult oncology patients undergoing these therapies.
Rating: Strong
Imperative-
Risks/Harms of Implementing This Recommendation
There are no potential risks or harms associated with the application of this recommendation.
-
Conditions of Application
There are no conditions which may limit the application of this recommendation.
-
Potential Costs Associated with Application
Although costs of medical nutrition therapy (MNT) sessions and reimbursement vary, MNT sessions including collaboration with other healthcare professionals, are essential for improved outcomes.
-
Recommendation Narrative
A total of 45 studies were included in the evidence analysis for this recommendation:
- Six positive-quality randomized controlled trials (RCT) [Barlow et al, 2011; Braga et al, 1998; Hyltander et al, 2005; Ionescu et al, 2009; Ravasco et al, 2005 (Head and Neck); Ravasco et al, 2005 (J Clin Oncology.)]
- Six positive-quality prospective cohort studies (Fearon et al, 2006; Hill et al, 2011; Laky et al, 2010; Ross et al, 2004; Sorensen et al, 2008; Tan et al, 2009)
- Three positive-quality diagnostic, validity or reliability studies (Amaral et al, 2008; Correia et al, 2007; Gioulbasanis et al, 2011)
- Three positive-quality case-control studies (Alexandre et al, 2003; Carey et al, 2011; Horsley et al, 2005)
- Two postive-quality retrospective cohort studies (Gupta et al, 2010; Yoon et al, 2011)
- Two positive-quality prospective cohort studies (Pressior et al, 2010; Prado et al, 2007)
- Two postive-quality cross-sectional studies (Isenring et al, 2003; Nourissat et al, 2008)
- One positive-quality prospective before-and-after study (Ravasco et al, 2003)
- Five neutral-quality prospective cohort studies (Martin et al, 2010; Martin and Lagergren, 2009; Prado et al, 2008; Prado et al, 2009; Prado et al, 2011)
- Two neutral-quality diagnostic, validity or reliability studies (Phippen et al 2011; Persson et al, 1999)
- Two neutral-quality non-controlled trials (Bauer et al, 2005; Capuano et al, 2008)
- Two neutral-quality prospective cohort studies (Antoun et al, 2009; Iversen et al, 2010)
- Two neutral-quality RCTs (Ollenschlager et al, 1992; Robinson et al, 2008)
- Two neutral-quality cross-sectional studies (Dewys et al, 1980; Shahmoradi et al, 2009)
- Two neutral-quality retrospective cohort studies (Eriksson et al, 1998; Kathiresan et al, 2011)
- One neutral-quality descriptive study (Hammerlid et al, 1998)
- One neutral-quality retrospective chart review (Odelli et al, 2005)
- One neutral-quality non-randomized controlled trial (Piquet et al, 2002).
Nutrition Status and Hospital Admissions or Re-admissions
- Five of six studies provide evidence that poor nutrition status is associated with higher rates of hospital admissions or re-admissions in adult oncology patients.
- Five studies found that a decreased nutrition status is associated with greater numbers of hospital admissions.
- A sixth study (Barlow et al, 2011) showed the same effect, but was not statistically significant.
- Evidence is based on the following studies: Barlow et al, 2011; Capuano et al, 2008; Hill et al, 2011; Kathiresan et al, 2011; Odelli et al, 2005; and Piquet et al, 2002.
Nutrition Status and Hospital LOS
- Ten of eleven studies provide evidence that poor nutrition status is associated with increased length of hospital stay (LOS) in adult oncology patients.
- Ten studies found that a decreased nutrition status is associated with longer LOS.
- One study (Hyltander et al, 2005) found no statistical difference between groups.
- Evidence is based on the following studies: Amaral et al, 2008; Antoun et al, 2009; Barlow et al, 2011; Braga et al, 1998; Horsley et al, 2005; Hyltander et al, 2005; Ionescu et al, 2009; Laky et al, 2010; Odelli et al, 2005; Pressoir et al, 2010; and Sorensen et al, 2008.
Nutrition Status and QOL
- Thirteen of 14 studies provide evidence that poor nutrition status is associated with lower quality of life (QoL) in adult oncology patients.
- Thirteen studies found that a decreased nutrition status is associated with a lower QoL.
- All eight of the studies utilizing the Patient-Generated Subjective Global Assessment (PG-SGA) found that a higher score (higher nutrition risk) was associated with a lower QoL in oncology patients.
- Only one study (Hammerlid et al, 1998) found minimal correlation between nutrition status and QoL.
- Thirteen studies found that a decreased nutrition status is associated with a lower QoL.
- Evidence is based on the following studies: Bauer et al, 2005; Carey et al, 2011; Correia et al, 2007; Fearon et al, 2006; Hammerlid et al, 1998; Hyltander et al, 2005; Isenring et al, 2003; Iversen et al, 2010; Nourissat et al, 2008; Ollenschlager et al, 1992; Ravasco et al, 2003; Ravasco et al, 2005 (J Clin Oncology); Ravasco et al, 2005 (Head and Neck); and Shahmoradi et al, 2009.
Nutrition Status and Radiation Treatment Tolerance
- Six studies provide evidence that poor nutrition status is associated with increased radiation treatment intolerance in adult oncology patients undergoing radiotherapy.
- All six studies found positive associations between nutrition status and two or more of the following: Reduced treatment interruptions, unplanned hospital admissions, treatment toxicity, PG-SGA score over time and QoL.
- Evidence is based on the following studies: Capuano et al, 2008; Hill et al, 2011; Odelli et al, 2005; Ravasco et al, 2003; Ravasco et al, 2005 (J Clin Oncology); Ravasco et al, 2005 (Head and Neck)
Nutrition Status and Chemotherapy Treatment Tolerance
- Ten of eleven studies provide evidence that poor nutrition status is associated with increased chemotherapy treatment intolerance in adult oncology patients undergoing chemotherapy.
- Ten studies found positive associations in one or more of the following: Treatment interruptions, infections, unplanned hospital admissions, treatment toxicity, including dose-limiting treatment toxicity, neutropenic fever, fatigue and severe thrombocytopenia.
- One study (Odelli, 2005) showed a similar trend toward fewer dose reductions, but the difference was NS.
- Evidence is based on the following eleven studies: Alexandre et al, 2003; Capuano et al, 2008; Eriksson et al, 1998; Hill et al, 2011; Odelli et al, 2005; Phippen et al, 2011; Prado et al, 2007; Prado et al, 2009; Prado et al, 2011; Robinson et al, 2008; and Ross et al, 2004
Nutrition Status and Mortality
- Sixteen of seventeen studies provide evidence that poor nutrition status is associated with mortality in adult oncology patients.
- Sixteen studies found positive associations among one or more of the following and mortality: weight loss, malnutrition, poor scores on validated malnutrition and quality of life screening tools, sarcopenia, cachexia, and fatigue.
- One study (Hyltander et al, 2005) did not find a relationship between nutrition status and mortality.
- Evidence is based on the following seventeen studies: Capuano et al, 2008; Dewys et al, 1980; Fearon et al, 2006; Gioulbasanis et al 2011; Gupta et al, 2010; Hammerlid et al, 1998; Hyltander et al, 2005; Martin and Lagergren, 2009; Martin et al, 2010; Persson et al, 1999; Prado et al, 2008; Pressoir et al, 2010; Robinson et al, 2008; Ross et al, 2004; Sorensen et al, 2008; Tan et al, 2009; Yoon et al, 2011
-
Recommendation Strength Rationale
- The conclusion statement for the relationship between nutrition status and hospital admissions or re-admissions is Grade II
- The conclusion statement for the relationship between nutrition status and hospital LOS is Grade I
- The conclusion statement for the relationship between nutrition status and QoL is Grade I
- The conclusion statement for the relationship between nutrition status and radiation treatment tolerance is Grade I
- The conclusion statement for the relationship between nutrition status and chemotherapy treatment tolerance is Grade I
- The conclusion statement for the relationship between nutrition status and mortality is Grade I.
-
Minority Opinions
None.
-
Risks/Harms of Implementing This Recommendation
-
Supporting Evidence
The recommendations were created from the evidence analysis on the following questions. To see detail of the evidence analysis, click the blue hyperlinks below (recommendations rated consensus will not have supporting evidence linked).
What is the relationship between nutrition status and hospital admissions or re-admissions in adult oncology patients?
What is the relationship between nutrition status and hospital length of stay (LOS) in oncology patients?
What is the relationship between nutrition status and quality of life (QOL) in oncology patients?
What is the relationship between nutrition status and radiation treatment tolerance in oncology patients?
What is the relationship between nutrition status and chemotherapy treatment tolerance in oncology patients?
What is the relationship between nutrition status and mortality in oncology patients?-
References
Barlow R, Price P, Reid TD, Hunt S, Clark GW, Havard TJ, Puntis MC, Lewis WG. Prospective multicentre randomised controlled trial of early enteral nutrition for patients undergoing major upper gastrointestinal surgical resection. Clin Nutr. 2011 Oct; 30(5): 560-566.
Capuano G, Grosso A, Gentile PC, Battista M, Bianciardi F, Di Palma A, Pavese I, Satta F, Tosti M, Palladino A, Coiro G, Di Palma M. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck. 2008 Apr; 30(4): 503-508.
Hill A, Kiss N, Hodgson B, Crowe TC, Walsh AD. Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients. Clin Nutr. 2011; 30: 92-98.
Kathiresan AS, Brookfield KF, Schuman SI, Lucci JA 3rd. Malnutrition as a predictor of poor postoperative outcomes in gynecologic cancer patients. Arch Gynecol Obstet. 2011 Aug; 284(2): 445-451.
Piquet MA, Ozsahin M, Larpin I, Zouhair A, Coti P, Monney M, Monnier P, Mirimanoff RO, Roulet M. Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy. Support Care Cancer. 2002 Sep; 10(6): 502-504. Epub 2002 Aug 2.
Amaral TF, Antunes A, Cabral S, Alves P, Kent-Smith L. An evaluation of three nutritional screening tools in a Portuguese oncology centre. J Hum Nutr Diet. 2008; 21: 575-583.
Antoun S, Rey A, Béal J, Montange F, Pressoir M, Vasson MP, Dupoiron D, Gourdiat-Borye A, Guillaume A, Maget B, Nitenberg G, Raynard B, Bachmann P. Nutritional risk factors in planned oncologic surgery: What clinical and biological parameters should be routinely used? World J Surg. 2009 Aug; 33(8): 1,633-1,640.
Braga M, Gianotti L, Vignali A, Cestari A, Bisagni P, Di Carlo V. Artificial nutrition after major abdominal surgery: Impact of route of administration and composition of the diet. Crit Care Med.1998; 26(1): 24-30.
Horsley P, Bauer J, Gallagher B. Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transplantation. 2005; 35: 1,113-1,116.
Ionescu D, Iancu C, Ion D, Al-Hajjar N, Margarit S, Mocan L, Mocan T, Deac D, Bodea R, Vasian H. Implementing fast-track protocol for colorectal surgery: A prospective randomized clinical trial. World J Surg. 2009 Nov; 33(11): 2,433-2,438.
Laky B, Janda M, Kondalsamy-Chennakesavan S, Cleghorn G, Obermair, A. Pretreatment malnutrition and quality of life-association with prolonged length of hospital stay among patients with gynecological cancer: A cohort study. BMC Cancer. 2010; 10: 232.
Pressoir M, Desne S, Berchery D, Rossignol G, Poiree B, Meslier M, Traversier S, Vittot M, Simon M, Gekiere JP, Meuric J, Serot F, Falewee MN, Rodriquez I, Senesse P, Vasson MP, Chelle F, Maget B, Antoun S, Bachmann P. Prevalence, risk factors and clinical implications of malnutrition in French comprehensive cancer centers. British Journal of Cancer. 2010: 102, 966-971.
Sorensen J, Kondrup J, Prokopowicz J, Schiesser M, Krähenbühl L, Meier R, Liberda M; EuroOOPS study group. EuroOOPS: An international, multicentre study to implement nutritional risk screening and evaluate clinical outcome. Clin Nutr. 2008 Jun; 27(3): 340-349.
Bauer JD, Capra S. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy-a pilot study. Support Care Cancer. 2005; 13: 270-274.
Carey S, Storey D, Biankin AV, Martin D, Young J, Allman-Farinelli M.Long-term nutritional status and quality of life following major upper gastrointestinal surgery: A cross-sectional study. Clin Nutr. 2011 Dec; 30(6): 774-779.
Correia M, Cravo M, Marques-Vidal P, Grimble R, Dias-Pereira A, Faias S, Nobre-Leitão C. Serum concentrations of TNF-alpha as a surrogate marker for malnutrition and worse quality of life in patients with gastric cancer. Clin Nutr. 2007 Dec; 26(6): 728-735.
Hammerlid E, Wirblad B, Sandin C, Mercke C, Edstrom S, Kaasa S, Sullivan M, Westin T. Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head & Neck. 1988; 20: 540-548.
Hyltander A, Bosaeus I, Svedlund J, Liedman B, Hugosson I, Wallengren O, Olsson U, Johnsson E, Kostic S, Henningsson A, Körner U, Lundell L, Lundholm K. Supportive nutrition on recovery of metabolism, nutritional state, health-related quality of life, and exercise capacity after major surgery: A randomized study. Clin Gastroenterol Hepatol. 2005 May; 3(5): 466-474.
Isenring E, Bauer J, Capra, S. The scored patient-generated subjective global assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. European Journal of Clinical Nutrition. 2003; 57, 305-309.
Iversen PO, Wisløff F, Gulbrandsen N. Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support. Clin Nutr. 2010 Aug; 29(4): 488-491.
Nourissat A, Vasson MP, Merrouche Y, Bouteloup C, Goutte M, Mille D, Jacquin JP, Collard O, Michaud P, Chauvin F. Relationship between nutritional status and quality of life in patients with cancer. Eur J Cancer. 2008 Jun; 44(9): 1,238-1,242.
Ollenschläger G;Thomas W;Konkol K;Diehl V;Roth E. Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia. Eur J Clin Invest 1992 Aug;22(8):546-53.
Ravasco P, Monteiro-Grillo I, Camilo ME. Does nutrition influence quality of life in cancer patients undergoing radiotherapy? Radiother Oncol. 2003 May; 67(2): 213-220.
Ravasco P, Monteiro-Grillo I, Vidal P, Camilo M. Dietary counseling improves patient outcomes: A prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncology. 2005; 23: 1,431-1,438.
Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Impact of nutrition on outcome: A prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head and Neck. 2005 Aug; 659-668.
Shahmoradi N, Kandiah M, Peng LS. Impact of nutritional status on the quality of life of advanced cancer patients in hospice home care. Asian Pac J Cancer Prev. 2009; 10(6): 1,003-1,009.
Odelli C, Burgess D, Bateman L, Hughes A, Ackland S, Gillies J, Collins CE. Nutrition support improves patient outcomes, treatment tolerance and admission characteristics in oesophagel cancer. Clinical Oncology. 2005;17:639-645.
Alexandre J, Gross-Goupil M, Falissard B, Nguyen ML, Gornet JM, Misset JL, Goldwasser F. Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. Ann Oncol. 2003; 14: 36-41.
Eriksson KM, Cederholm T, Palmblad JE. Nutrition and acute leukemia in adults: Relation between nutritional status and infectious complications during remission induction. Cancer. 1998; 82: 1,071-1,077.
Phippen NT, Lowery WJ, Barnett JC, Hall LA, Landt C, Leath CA 3rd. Evaluation of the Patient-Generated Subjective Global Assessment (PG-SGA) as a predictor of febrile neutropenia in gynecologic cancer patients receiving combination chemotherapy: A pilot study. Gynecol Oncol. 2011; 123(2): 360-364.
Prado CM, Baracos VE, McCargar JL, Mourtzakis M, Mulder KE, Reiman T, Butter CA, Scarfe AG, Sawyer MB. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res. 2007 Jun 1; 13(11): 3,264-3,268.
Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009 Apr 15; 15(8) :2,920-2,926.
Prado CM, Lima IS, Baracos VE, Bies RR, McCargar LJ, Reiman T, Mackey JR, Kuzma M, Damaraju VL, Sawyer MB. An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity. Cancer Chemother Pharmacol. 2011; 67(1): 93-101.
Robinson DW Jr, Eisenberg DF, Cella D, Zhao N, de Boer C, DeWitte M. The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia. J Support Oncol. 2008; 6(6): 283-290.
Ross PJ, Norton A, Priest K, Waters JS, Eisen T, Smith IE, O'Brien MER. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? British Journal of Cancer. 2004; 90: 1,905-1,911.
Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980; 69(4): 491-497.
Fearon KC, Voss AC, Hustead DS. Definition of cancer cachexia: Effect of weight loss, reduced food intake and systemic inflammation on functional status and prognosis. American Society of Nutrition. 2006; 83: 1,345-1,350.
Gioulbasanis I, Georgoulias P, Vlachostergios PJ, Baracos V, Ghosh S, Giannousi Z, Papandreou CN, Mavroudis D, Georgoulias V. Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: Interrelations and associations with prognosis. Lung Cancer. 2011 Dec; 74(3): 516-520.
Gupta D, Lis CG, Vashi PG, Lammersfeld CA. Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer. 2010 Mar; 18(3): 373-381.
Martin L, Lagergren P. Long-term weight change after oesophageal cancer surgery. B J Surg. 2009; 96 (11): 1,308-1,314.
Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H, Atkins M, Fassbender K, Downing GM, Baracos V. Prognostic factors in patients with advanced cancer: Use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol. 2010 Oct 1; 28(28): 4,376-4,383.
Persson C, Sjoden PO, Glimellius B. The Swedish version of the patient-generated subjective global assessment of nutritional status: gastrointestinal vs urological cancers. Clin Nutr. 1999; 18 (2): 71-77.
Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 2008; 9(7): 629-635.
Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009 Nov 15; 15(22): 6,973-6,979.
Yoon H, Lewis M, Shi Q, Khan M, Cassivi S, Diasio R, Sinicrope F. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol. 2011; 29: 4,561-4,567. -
References not graded in Academy of Nutrition and Dietetics Evidence Analysis Process
None.
-
References